pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
toviblideg
Follicular Lymphoma
Bristol-Myers Squibb Co
0
catalysts
Phase 2
trabedersen
Oncomun (trabedersen [INN])
Metastatic Melanoma
Sapu Bioscience LLC
0
catalysts
Phase 2
traxivitug
Polyomavirus Infections
$VERA
Vera Therapeutics, Inc.
0
catalysts
Phase 2
trevotamig
← prev
page 48 of 50
next →
131
Pain
89
Neurology
1
trevotamig [INN]
Adenocarcinoma
$BCAB
BioAtla, Inc.
0
catalysts
Phase 2
trientine hydrochloride
Trientine Hydrochloride (trientine hydrochloride)
Congestive Heart Failure (Heart Failure)
Innolife Co Ltd
0
catalysts
Phase 2
trimetazidine
trimetazidine [INN]
Contrast Induced Nephropathy
Saghmos Therapeutics Inc
0
catalysts
Phase 2
troculeucel
troculeucel [INN]
Alzheimer's Disease
NKGen Biotech Inc
0
catalysts
Phase 2
trovostobart
trovostobart [INN]
Bladder Cancer
TuHURA Biosciences Inc
0
catalysts
Phase 2
tucidinostat
Metastatic Melanoma
HUYA Bioscience International LLC
0
catalysts
Phase 2
tulmimetostat
Endometrial Cancer
$NVS
NOVARTIS AG
0
catalysts
Phase 2
tuspetinib
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$APTOF
Aptose Biosciences Inc.
0
catalysts
Phase 2
tuvatexib
tuvatexib [INN]
Actinic (Solar) Keratosis
Vidac Pharma
0
catalysts
Phase 2
ulacamten
Diastolic Heart Failure (HFpEF)
$CYTK
CYTOKINETICS INC
0
catalysts
Phase 2
ulenistamab
ulenistamab [INN]
Metastatic Pancreatic Cancer
Prestige BioPharma Ltd
0
catalysts
Phase 2
umitrelimorgene autodencel
umitrelimorgene autodencel [INN]
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
0
catalysts
Phase 2
unasnemab
Traumatic Spinal Cord Injury
Repulsive guidance molecule A
Tanabe Pharma Corp
0
catalysts
Phase 2
urcosimod
Keratoconjunctivitis Sicca (Dry Eye)
$OKYO
OKYO Pharma Ltd
0
catalysts
Phase 2
usnoflast
Amyotrophic Lateral Sclerosis
Zydus Lifesciences Ltd
0
catalysts
Phase 2
utenpanium chloride
Obesity
Raziel Therapeutics
0
catalysts
Phase 2
utidelone
utidelone [INN]
Breast Cancer
BioStar Pharmaceuticals Inc
0
catalysts
Phase 2
uzatresgene autoleucel
Ovarian Cancer
US WorldMeds LLC
0
catalysts
Phase 2
vabametkib
vabametkib [INN]
Non-Small Cell Lung Cancer
Abion Inc
0
catalysts
Phase 2
vadernersen sodium
X Chromosome Disorders
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
Phase 2
vafidemstat
vafidemstat [INN]
Borderline Personality Disorder (BPD)
Oryzon Genomics SA
0
catalysts
Phase 2
valemetostat
valemetostat [INN]
Non-Small Cell Lung Cancer
Daiichi Sankyo Co Ltd
0
catalysts
Phase 2
vamotinib
vamotinib [INN]
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Fusion Pharmaceuticals Inc
0
catalysts
Phase 2
vandefitemcel
vandefitemcel [INN]
Traumatic Brain Injury
SanBio Co Ltd
0
catalysts
Phase 2
vanoglipel
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$MTVA
MetaVia Inc.
0
catalysts
Phase 2
varespladib methyl
Poisoning
Group 10 secretory phospholipase A2
Phospholipase A2, membrane associated
Ophirex Inc
0
catalysts
Phase 2
vebreltinib DR
vebreltinib
Glioblastoma Multiforme (GBM)
$APLM
Apollomics Inc.
0
catalysts
